Breaking Netanyahu and Trump Discuss Regional Tensions and Abraham Accords France and Spain Battle Worst Wildfires Since WWII Amid Heat Wave Concerns Senator Lindsey Graham Honored in Washington D.C. Services Judge Orders Release of Key Witness in ICE Shooting Case Bryan Kohberger Seeks to Withdraw Guilty Plea, Cites Coercion by Attorneys

Tuesday July 28, 2026

Reporter

Ascletis Pharma Inc.

2Articles Published

5Communities Covered

Published Articles

Press Release

Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model

Jul 27

Press Release

Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting

Jul 22